B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

Details for Australian Patent Application No. 2005295038 (hide)

Owner Mayo Foundation for Medical Education and Research

Inventors Cheng, Lieping; Kwon, Eugene D.; Strome, Scott E.

Agent Callinan

Pub. Number AU-B-2005295038

PCT Pub. Number WO2006/042237

Priority 60/616,590 06.10.04 US; 60/642,794 11.01.05 US

Filing date 6 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 17 May 2012

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/042237 Priority application(s): WO2006/042237

17 May 2012 Application Accepted

  Published as AU-B-2005295038

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295039-Methods of storing tissue matrices

2005295033-Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins